We discussed with Thierry Cournez, effective ways for emerging biotechs to collect material quickly and cost-effectively for pre-clinical and clinical studies.

Cell counting is a challenging technique, with many pitfalls, that can delay entire projects. We talk with Christian Berg about how new technologies are solving these challenges and enabling standardization of cell counting across organizations.

3D cell culture techniques have become popular because the cell morphology, interactions and tissue-specific architecture more closely resembles that of in vivo tissues.

In this podcast, we talked with Dr. Gil Van Bokkelen, Chairman and CEO, Athersys about recent clinical breakthroughs in regenerative medicine and manufacturing challenges. We also discussed Multistem and how it has been demonstrated to help patients wi...

In this podcast, we conducted a panel discussion with experts from Selexis and KBI Biopharma on bi-specific antibodies. We examined bi-specific antibody development and manufacturing, including current challenges and key solutions.

Dr. Glenn Harris talks about the benefits and challenges of implementing rapid media analysis in process development, including the bottleneck created by outsourcing samples to core labs. We also discussed an easy to implement,

Dr. Tobias Hertzig and Dr. Ulrich Tillmann talk about non-animal origin cell culture media supplements. The regulatory advantages of non-animal origin, performance vs. animal origin material and the manufacturing process.

Challenges and solutions for isolation, expansion and maintenance

In this podcast, I talked with Max Blomberg, Executive Director of Operations and Andrew Govea, Senior Product Engineer, Meissner about the challenges of handling bulk drug substance, specifically fr

Benefits of real-time live-cell analysis and image processing workflows